Sandra A. Rebuffat

705 total citations
24 papers, 541 citations indexed

About

Sandra A. Rebuffat is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Sandra A. Rebuffat has authored 24 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Sandra A. Rebuffat's work include Thyroid Disorders and Treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Pancreatic function and diabetes (6 papers). Sandra A. Rebuffat is often cited by papers focused on Thyroid Disorders and Treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Pancreatic function and diabetes (6 papers). Sandra A. Rebuffat collaborates with scholars based in France, Spain and United States. Sandra A. Rebuffat's co-authors include Sylvie Péraldi‐Roux, Ramón Gomis, Hammadi Ayadi, Damien Bresson, Joana Oliveira, Bruno Robert, Rosa Gasa, Laurence Briant, Christian Devaux and Ramón Gomis and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Sandra A. Rebuffat

23 papers receiving 526 citations

Peers

Sandra A. Rebuffat
Fuyan Sun Japan
M Hoffman United States
Brian Van Yserloo United States
Zhaoying Xiang United States
Dongfei Qi United States
Ju Youn Kim South Korea
Hann Low Australia
Xuezhu Li China
Fuyan Sun Japan
Sandra A. Rebuffat
Citations per year, relative to Sandra A. Rebuffat Sandra A. Rebuffat (= 1×) peers Fuyan Sun

Countries citing papers authored by Sandra A. Rebuffat

Since Specialization
Citations

This map shows the geographic impact of Sandra A. Rebuffat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A. Rebuffat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A. Rebuffat more than expected).

Fields of papers citing papers by Sandra A. Rebuffat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A. Rebuffat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A. Rebuffat. The network helps show where Sandra A. Rebuffat may publish in the future.

Co-authorship network of co-authors of Sandra A. Rebuffat

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A. Rebuffat. A scholar is included among the top collaborators of Sandra A. Rebuffat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A. Rebuffat. Sandra A. Rebuffat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivière, Benjamin, Audrey Jaussent, Valérie Macioce, et al.. (2022). The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes & Metabolism. 48(4). 101345–101345. 29 indexed citations
2.
Galtier, Florence, Sandra A. Rebuffat, Nicolas Provost, et al.. (2022). Addressing the quality challenge of a human biospecimen biobank through the creation of a quality management system. PLoS ONE. 17(12). e0278780–e0278780. 6 indexed citations
3.
Duranton, Flore, Caroline Desmetz, Nathalie de Préville, et al.. (2021). Optimization of RNA extraction methods from human metabolic tissue samples of the COMET biobank. Scientific Reports. 11(1). 20975–20975. 14 indexed citations
4.
Rebuffat, Sandra A., Emmanuelle Sidot, Jacqueline Azay-Milhau, et al.. (2018). Adipose tissue derived-factors impaired pancreatic β-cell function in diabetes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(10). 3378–3387. 25 indexed citations
5.
Rebuffat, Sandra A., et al.. (2016). Taurine Treatment Modulates Circadian Rhythms in Mice Fed A High Fat Diet. Scientific Reports. 6(1). 36801–36801. 25 indexed citations
6.
Malpique, Rita, Yaiza Esteban, Sandra A. Rebuffat, et al.. (2014). Integrative analysis reveals novel pathways mediating the interaction between adipose tissue and pancreatic islets in obesity in rats. Diabetologia. 57(6). 1219–1231. 7 indexed citations
7.
Oliveira, Joana, Sandra A. Rebuffat, Rosa Gasa, & Ramón Gomis. (2014). Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2. Canadian Journal of Physiology and Pharmacology. 92(8). 613–620. 31 indexed citations
8.
Canivell, Sílvia, Sandra A. Rebuffat, Elena G. Ruano, et al.. (2014). Circulating SFRP5 levels are elevated in drug‐naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes/Metabolism Research and Reviews. 31(2). 212–219. 29 indexed citations
9.
Rebuffat, Sandra A., Joana Oliveira, Jordi Altirriba, et al.. (2013). Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat. Diabetologia. 56(11). 2446–2455. 30 indexed citations
10.
Mnif, Mouna, Sandra A. Rebuffat, Ahmed Rebaï, et al.. (2012). IL-1β a potential factor for discriminating between thyroid carcinoma and atrophic thyroiditis. European Cytokine Network. 23(3). 101–106. 12 indexed citations
11.
Rebuffat, Sandra A., et al.. (2012). IL-1β and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases. Immunobiology. 218(3). 285–291. 39 indexed citations
12.
Rebuffat, Sandra A., et al.. (2010). Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO. British Journal of Cancer. 102(5). 852–861. 11 indexed citations
13.
Rebuffat, Sandra A., Ilhem Charfeddine, Mouna Mnif, et al.. (2010). SLC26A4 expression among autoimmune thyroid tissues. Immunobiology. 216(5). 571–578. 8 indexed citations
14.
Rebuffat, Sandra A., et al.. (2010). Absence of anti-pendrin auto-antibodies in the sera of Tunisian patients with autoimmune thyroid diseases.. PubMed. 56(7-8). 335–43. 5 indexed citations
15.
Rebuffat, Sandra A., et al.. (2009). Autoimmune thyroid diseases: genetic susceptibility of thyroid‐specific genes and thyroid autoantigens contributions. International Journal of Immunogenetics. 36(2). 85–96. 49 indexed citations
16.
Rebuffat, Sandra A., et al.. (2006). The key residues in the immunodominant region 353–363 of human thyroid peroxidase were identified. International Immunology. 18(7). 1091–1099. 10 indexed citations
17.
Bresson, Damien, Sandra A. Rebuffat, & Sylvie Péraldi‐Roux. (2005). Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: an update. PubMed. 2(1). 2–2. 17 indexed citations
18.
Bresson, Damien, et al.. (2005). New Insights into the Conformational Dominant Epitopes on Thyroid Peroxidase Recognized by Human Autoantibodies. Endocrinology. 146(6). 2834–2844. 16 indexed citations
19.
Rebuffat, Sandra A., et al.. (2004). The Host Cell MAP Kinase ERK-2 Regulates Viral Assembly and Release by Phosphorylating the p6 Protein of HIV-1. Journal of Biological Chemistry. 279(31). 32426–32434. 68 indexed citations
20.
Bresson, Damien, Martine Pugnière, Françoise Roquet, et al.. (2004). Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies. Journal of Biological Chemistry. 279(37). 39058–39067. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026